The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery

Ear, Nose and Throat Journal

Volumn 86, Issue 7, 2007, Pages 396-399

  Kim, Ji Eon ^a   Kountakis, Stilianos E ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MUCOLYTIC AGENT; STEROID; ACETYLSALICYLIC ACID;

ADOLESCENT; ADULT; AGED; ANOSMIA; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOSCOPIC SURGERY; FACE PAIN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE DISEASE; NOSE OBSTRUCTION; NOSE POLYP; NOSE SURGERY; POSTNASAL DRIP; PREVALENCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RHINOSINUSITIS; STATISTICAL SIGNIFICANCE; CHRONIC DISEASE; COMORBIDITY; DRUG HYPERSENSITIVITY; ENDOSCOPY; MIDDLE AGED; PRESCHOOL CHILD; RHINITIS; SINUSITIS; SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; ASTHMA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COMORBIDITY; DRUG HYPERSENSITIVITY; ENDOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; RHINITIS; SINUSITIS; SYNDROME;

EID: 34548541959     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130708600715     Document Type: Article

References (19)

1. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68(5):975-83.
2. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988;137(4):847-54.
3. Knapp HR, Sladek K, Fitzgerald GA. Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med 1992;119(1):48-51.
4. Antczak A, Montuschi P, Kharitonov S, et al. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002;166(3):301-6.
5. Moloney JR. Nasal polyps, nasal polypectomy, asthma, and aspirin sensitivity. Their association in 445 cases of nasal polyps. J Laryngol Otol 1977;91(10):837-46.
6. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328(7437):434.
7. Michel O, Naeije N, Bracamonte M, et al. [Indications for the aspirin provocation test in the asthmatic]. Rev Pneumol Clin 1984;40(6):369-71.
8. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111(5):913-21.
9. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28(4):717-22.
10. Weber RW, Hoffman M, Raine DA Jr., Nelson HS. Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol 1979;64(1):32-7.
11. Vally H, Taylor ML, Thompson PJ. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002;57(7):569-74.
12. Settipane RA, Stevenson DD. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1989;84(1):26-33.
13. Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003;111(5):1116-21.
14. Martin-Garcia C, Hinojosa M, Berges P, et al. Safety of cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 2002;121(6):1812-17.
15. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108(1):47-51.
16. Szczeklik A, Nizankowska E, Bochenek G, et al. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31(2):219-25.
17. Woessner KM, Simon RA, Stevenson DD. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002;46(8):2201-6.
18. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization - treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990;85(1 Pt 1):59-65.
19. Dahlen SE, Malmstrom K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: A randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002;165(1):9-14.